Overview
Beacon Platform combining FDA-cleared wearable EEG (Waveband, formerly Dreem 3S) with AI analytics for sleep, neurology, and psychiatry — serving biopharma clinical trials, diagnostics, and at-home brain monitoring programs.
Product and company
Beacon Platform is a verified product offering linked to the Brel Digital company profile for Beacon Biosignals.
Use cases
Beacon Platform combining FDA-cleared wearable EEG (Waveband, formerly Dreem 3S) with AI analytics for sleep, neurology, and psychiatry — serving biopharma clinical trials, diagnostics, and at-home brain monitoring programs.
Target customer
Biopharmaceutical companies needing objective EEG endpoints in CNS trials, sleep medicine clinicians, and research organizations measuring brain function in real-world settings.
Technologies
Primary technologies assigned from the linked company profile: Deep Learning, Healthcare Analytics, Machine Learning, Predictive Analytics.
Sources and references
- Official product / company source: https://beacon.bio/news/beacon-biosignals-upsizes-series-b-to-over-97-million
- Supporting source: https://beacon.bio/about
Product facts are limited to information already verified on the linked Brel company profile and its cited official URLs. No speculative capabilities are added.
Last reviewed
This product profile was last reviewed on 2026-07-14.
Correction request
If this product record is inaccurate or outdated, submit a correction through Brel Digital’s Corrections Policy.
Features and capabilities
- Beacon Platform combining FDA-cleared wearable EEG (Waveband, formerly Dreem 3S) with AI analytics for sleep, neurology
- FDA-cleared wearable EEG (Waveband
- formerly Dreem 3S) with AI analytics for sleep
- neurology
- and psychiatry — serving biopharma clinical trials
- diagnostics
- and at-home brain monitoring programs
Extracted from the linked company product description already verified on Brel. No capabilities were invented.